Table 1.

Correlation Between GRB2 Expression and Clinicopathological Characteristics of HCC Patients

Variable	Patients		P
	GRB2Low	GRB2High
Gender
Female	11	13	0.133
Male	40	61
Age (years)
≥52	26	30	0.097
<52	25	44
Liver cirrhosis
Positive	34	64	0.007**
Negative	17	10
HBsAg
Positive	27	43	0.537
Negative	24	31
HCV
Positive	2	5	0.444a
Negative	49	69
Tbil, μmol/L
≥17	14	26	0.453
<17	37	48
ALT, U/L
≥75	4	8	0.653
<75	47	66
AFP, ng/mL
≥20	23	38	0.484
<20	28	36
Tumor size (cm)
≥5	27	57	0.002**
<5	24	17
Tumor encapsulation
Positive	26	44	0.536
Negative	25	30
Tumor number
Single	43	60	0.646
Multiple	8	14
Vascular tumor thrombus
Positive	10	23	0.143
Negative	41	51
TNM
I	41	49	0.049*
II+III	10	25

Notes: ^aFisher test; bold type is considered statistically significant; *P < 0.05; **P < 0.01.